Pular para o conteúdo principal
Ranking Invest

RCEL - AVITA Medical, Inc.

Segmento: HealthcareAVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Análise Ranking Invest

Valuation estimado
-$ 210.11 Mi
Valor de Mercado
$ 305.09 Mi
Desconto (AV)-245.2%
IVR
-0.69A companhia vale -0,69 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.59O valuation alternativo equivale a -59% do valor de mercado da companhia.
MLL
-0.59O lucro líquido dos controladores em 16 trimestres equivale a -59% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

-$ 27.84 Mi

Dívida Líquida

$ 37.52 Mi

L4T

-$ 43.08 Mi

MM4T

-58.42%

Indicadores Básicos

ROE

154.76%

Índices de Previsibilidade

Receita Líquida

E0.14

Lucro

B0.23

Margem

B0.26

Índices de Tendência

Receita Líquida

B7.68

Lucro

D0.93

Margem

B4.73

Índices de Endividamento

DIV/PAT

-1.35

DIV/L4T

-0.87

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.